(Q46922494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Olivier Hermine

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Murielle Roussel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Emmanuel Gyan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

René-Olivier Casasnovas

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Remy Gressin

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Noel Jean Milpied

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Catherine Thieblemont

7

object named as

Catherine Thieblemont

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

Reda Bouabdallah

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

12

Franck Morschhauser

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

5

Richard Delarue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

23

Steven Le Gouill

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Anne-Sophie Michallet

15

object named as

Anne-Sophie Michallet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

17

Gandhi Damaj

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Cyrille Touzeau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Christophe Leux

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Krimo Bouabdallah

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Victoria Cacheux

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Laetitia Compain

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Marie-Pierre Moles

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Christian Rose

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Anne Sirvent

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mohamad Mohty

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

16 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

233-242

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

Advances in the understanding of mantle cell lymphoma

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Treatment of younger patients with mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Treatment of elderly patients with mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: res

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Treatment of older patients with mantle-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-013-1860-8

10.1007/S00277-013-1860-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23949376%20AND%20SRC:MED&resulttype=core&format=json